Compounds that modulate autoimmunity and methods of using the same
US9629848B2 · kind B2 · utility
5Cited by
6References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 29, 2012 |
| Grant date | Apr 25, 2017 |
| Priority date | — |
| Expiry date | Jul 19, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods of preventing, treating or ameliorating autoimmune diseases, such as diabetes and celiac disease, by decreasing the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease by the administration of small organic compounds. The invention also provides pharmaceutical compositions comprising the therapeutically effective small organic compounds and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.